On March 18, two kinds of patents that can effectively use local resources were successfully declared, and 10 billion Hong Kong dollars supported the development of the flax industry chain in Gansu Province. Lianlian Xi reported that the joint venture project of "coordination of fatty acid proportions in the coordination of edible oil application and the modernization of the flax industry has started. "The press conference was uploaded. In the people's anticipation, Gansu Futai Bio and Hong Kong Jiajun have finally signed a contract to jointly create a flax industry chain for the benefit of the people of Liaoyuan.
The planting area and quality of flax are the first in the country. The Dingxi region is the main flax production base in our province. For many years, patented products of linolenic acid have been monopolized by developed countries as high-tech, high-value-added products in food additives, and it has been difficult for the northwestern region to form an upper-scale and higher-grade enterprise. For Dingxi, this is a good opportunity because Dingxi is very suitable for large-scale planting of flax, which not only helps farmers to get rid of poverty, but also effectively manages the loss of water and soil, and fundamentally improves the ecological environment. Gansu Futai Bio-Pharmaceutical Co., Ltd. and the Institute of Coal Chemistry of the Chinese Academy of Sciences in Shanxi Province have jointly developed a series of high-tech products based on flaxseed as raw materials. Among them, A linolenic acid and A linoleic acid ethyl ester have obtained the national patent certificate. , The technological level is in a leading position at home and abroad. Hong Kong Jiajun Group is very optimistic about the prospects for the development of the industry, ready to invest 1 billion yuan to invest. It will boost the economic development of Gansu Province and benefit the people of Long Valley. It will also solve the employment problem of more than 3,000 local farmers.
Gansu Futai Bio-Pharmaceutical Co., Ltd. invested in Dingxi to build a modern technology industrial base of flax series, covering an area of ​​200 acres, with a total investment of over 800 million yuan, of which fixed assets investment was 641 million yuan and current capital investment was 170.5 million yuan, all construction period It is 2 years. At present, the base has been approved by the National Development and Reform Commission as a "agricultural high-tech industrialization demonstration project." In addition, a total investment of 117 million yuan in Langzhong County, Lanzhou City, modern Chinese medicine and technology industrial base, a total investment of 20 million yuan in Baiyin City, a modern production and processing base of Chinese medicine Pieces and a total investment of 811.5 million in Dingxi City flax series of modern technology industry base is Plan to start implementation.
According to reports, China is one of the world's main producing countries of flax, which is second only to Canada and India, ranking third, with the total output ranked second. Gansu is one of the main producing provinces of flax in China, and the planting area and quality of flax are the first in the country. But for a long time, domestic development and utilization of flaxseeds was limited to edible oils and industrial oils, resulting in a huge waste of resources.
Hong Kong Jiajun Group very much looks forward to the development prospects of the industry, and is ready to spend RMB 1 billion to invest. It is understood that this will solve the employment problem of more than 3,000 local farmers in Gansu. Gansu Futai Bio-Pharmaceutical Engineering Co., Ltd. invested in Dingxi to build a modern technology industrial chain base of flax series, with a total investment of over 811,500 million yuan, and the construction period of all projects is 2 years.
For a long time, domestic development and utilization of flaxseeds was limited to edible oils and industrial oils, resulting in great waste of resources. As a natural food additive, flaxseed gum has a large domestic demand, but due to the reasons of the technology and raw materials, the quality of domestic seed gum is not satisfactory.
Gansu is one of the major provinces for producing flax in China. The area of ​​flax cultivation and the quality of its varieties are the first in the country. Gansu Futai Bio-Pharmaceutical Engineering Co., Ltd. based on the abundant flax resources in Gansu and the scientific and technological advantages of the company's biopharmaceuticals, cooperated with the Shanxi Coal Chemical Research Institute of the Chinese Academy of Sciences to develop linseed gum series products and developed a natural flaxseed gum, There are four kinds of high-tech products: edible oil, a-linolenic acid and a-linolenic acid. At present, among the four products, edible oils with a balanced proportion of linseed gum and fatty acids have been formally applied for national patents. A-linolenic acid and a-linolenic acid ethyl ester have been authorized by the Patent Office of the State Patent Office. The established joint venture, Gansu Futai Biotechnology Co., Ltd. will mainly carry out the industrial production of flaxseed glue series products, and raise the level of flax industry and technology content in Gansu.
The planting area and quality of flax are the first in the country. The Dingxi region is the main flax production base in our province. For many years, patented products of linolenic acid have been monopolized by developed countries as high-tech, high-value-added products in food additives, and it has been difficult for the northwestern region to form an upper-scale and higher-grade enterprise. For Dingxi, this is a good opportunity because Dingxi is very suitable for large-scale planting of flax, which not only helps farmers to get rid of poverty, but also effectively manages the loss of water and soil, and fundamentally improves the ecological environment. Gansu Futai Bio-Pharmaceutical Co., Ltd. and the Institute of Coal Chemistry of the Chinese Academy of Sciences in Shanxi Province have jointly developed a series of high-tech products based on flaxseed as raw materials. Among them, A linolenic acid and A linoleic acid ethyl ester have obtained the national patent certificate. , The technological level is in a leading position at home and abroad. Hong Kong Jiajun Group is very optimistic about the prospects for the development of the industry, ready to invest 1 billion yuan to invest. It will boost the economic development of Gansu Province and benefit the people of Long Valley. It will also solve the employment problem of more than 3,000 local farmers.
Gansu Futai Bio-Pharmaceutical Co., Ltd. invested in Dingxi to build a modern technology industrial base of flax series, covering an area of ​​200 acres, with a total investment of over 800 million yuan, of which fixed assets investment was 641 million yuan and current capital investment was 170.5 million yuan, all construction period It is 2 years. At present, the base has been approved by the National Development and Reform Commission as a "agricultural high-tech industrialization demonstration project." In addition, a total investment of 117 million yuan in Langzhong County, Lanzhou City, modern Chinese medicine and technology industrial base, a total investment of 20 million yuan in Baiyin City, a modern production and processing base of Chinese medicine Pieces and a total investment of 811.5 million in Dingxi City flax series of modern technology industry base is Plan to start implementation.
According to reports, China is one of the world's main producing countries of flax, which is second only to Canada and India, ranking third, with the total output ranked second. Gansu is one of the main producing provinces of flax in China, and the planting area and quality of flax are the first in the country. But for a long time, domestic development and utilization of flaxseeds was limited to edible oils and industrial oils, resulting in a huge waste of resources.
Hong Kong Jiajun Group very much looks forward to the development prospects of the industry, and is ready to spend RMB 1 billion to invest. It is understood that this will solve the employment problem of more than 3,000 local farmers in Gansu. Gansu Futai Bio-Pharmaceutical Engineering Co., Ltd. invested in Dingxi to build a modern technology industrial chain base of flax series, with a total investment of over 811,500 million yuan, and the construction period of all projects is 2 years.
For a long time, domestic development and utilization of flaxseeds was limited to edible oils and industrial oils, resulting in great waste of resources. As a natural food additive, flaxseed gum has a large domestic demand, but due to the reasons of the technology and raw materials, the quality of domestic seed gum is not satisfactory.
Gansu is one of the major provinces for producing flax in China. The area of ​​flax cultivation and the quality of its varieties are the first in the country. Gansu Futai Bio-Pharmaceutical Engineering Co., Ltd. based on the abundant flax resources in Gansu and the scientific and technological advantages of the company's biopharmaceuticals, cooperated with the Shanxi Coal Chemical Research Institute of the Chinese Academy of Sciences to develop linseed gum series products and developed a natural flaxseed gum, There are four kinds of high-tech products: edible oil, a-linolenic acid and a-linolenic acid. At present, among the four products, edible oils with a balanced proportion of linseed gum and fatty acids have been formally applied for national patents. A-linolenic acid and a-linolenic acid ethyl ester have been authorized by the Patent Office of the State Patent Office. The established joint venture, Gansu Futai Biotechnology Co., Ltd. will mainly carry out the industrial production of flaxseed glue series products, and raise the level of flax industry and technology content in Gansu.
Our Small Port has a good sealing ability and stable chemical properties. The excellent chemical resistance,heat resistance and good compatibility with the Drugs give us a guarantee to use the products safely. From the input to the output, the products go through a series of professional tests and strict quality controlling procedure. The joint is produced in the clean plant with the whole working plant reaching to Class 10000, and some even for Class 100 million grade. Our workshops are designed which meet the GMP standard.
Small Port
Small Port,Small Dual Port,Small Single Port,Small Round Ports
SUZHOU CRH PHARMACEUTICAL TECHNOLOGY CO.,LTD , http://www.crh-health.com